FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: ValueSet/2.16.840.1.113762.1.4.1151.17

Packageus.nlm.vsac
Resource TypeValueSet
Id2.16.840.1.113762.1.4.1151.17
FHIR VersionR4
Sourcehttp://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1151.17/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17
Version20170216
Statusactive
Date2017-02-16T01:00:02-05:00
NameHighGradeBladderCancerTaForUrologyCare
TitleHigh grade bladder cancer Ta for Urology Care
Realmus
Authorityhl7
Purpose(Clinical Focus: The high grade delineation is for the Primary Tumor (t) as related to bladder cancer. This is a noninvasive papillary carcinoma.),(Data Element Scope: The intent of this data element is to identify patients with high grade Ta bladder cancer which is non muscle invasive.),(Inclusion Criteria: High grade Ta nonmuscle invasive bladder cancer.),(Exclusion Criteria: Any Primary Tumor (T) stage other than Ta or low grade Ta.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
sctSNOMED CT (all versions)

Narrative

No narrative content found in resource


Source

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1151.17",
  "meta": {
    "versionId": "3",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "Oregon Urology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-02-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2017-02-16"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.17",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1151.17"
    }
  ],
  "version": "20170216",
  "name": "HighGradeBladderCancerTaForUrologyCare",
  "title": "High grade bladder cancer Ta for Urology Care",
  "status": "active",
  "experimental": false,
  "date": "2017-02-16T01:00:02-05:00",
  "publisher": "Oregon Urology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The high grade delineation is for the Primary Tumor (t) as related to bladder cancer.  This is a noninvasive papillary carcinoma.),(Data Element Scope: The intent of this data element is to identify patients with high grade Ta bladder cancer which is non muscle invasive.),(Inclusion Criteria: High grade Ta nonmuscle invasive bladder cancer.),(Exclusion Criteria: Any Primary Tumor (T) stage other than Ta or low grade Ta.)",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "371469007",
            "display": "Histologic grade (observable entity)"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:894968bf-a56b-41fe-8b94-298695d06aec",
    "timestamp": "2025-05-23T18:58:19-04:00",
    "total": 1,
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "371469007",
        "display": "Histologic grade of neoplasm (observable entity)"
      }
    ]
  }
}